"A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors."

Written By SP STUDIOS

AUTHORS: Gulam A. Manji, Brian A. Van Tine, Shing M. Lee, Alexander G. Raufi, Ilenia Pellicciotta, Angela C. Hirbe, Jaya Pradhan, Andrew Chen, Raul Rabadan, Gary K. Schwartz.

American Association for Cancer Research. 2021 Sept 7. doi: 10.1158/1078-0432.CCR-21-1779



SP STUDIOS https://spstudios.com
Previous

“Recombination and lineage-specific mutations led to the emergence of SARS-CoV-2.”
Next

“Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia”